Literature DB >> 1433504

Localization of an immunodominant domain on baculovirus-produced parvovirus B19 capsids: correlation to a major surface region on the native virus particle.

C S Brown1, T Jensen, R H Meloen, W Puijk, K Sugamura, H Sato, W J Spaan.   

Abstract

An immunodominant region on baculovirus-produced parvovirus B19 VP2 capsids was localized between amino acids 259 and 426 by mapping the binding sites of a panel of monoclonal antibodies which recognize determinants on the particles. The binding sites of three monoclonal antibodies were fine-mapped within this antigenic domain. Six VP2-specific monoclonal antibodies recognized determinants common to both the empty capsids and native parvovirus. The defined antigenic region is most probably exposed on the native B19 virion and corresponds to part of the threefold spike on the surface of canine parvovirus particles.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1433504      PMCID: PMC240344     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  The three-dimensional structure of canine parvovirus and its functional implications.

Authors:  J Tsao; M S Chapman; M Agbandje; W Keller; K Smith; H Wu; M Luo; T J Smith; M G Rossmann; R W Compans
Journal:  Science       Date:  1991-03-22       Impact factor: 47.728

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Prolonged parvovirus B19 infection with severe anaemia in a bone marrow transplant patient.

Authors:  H T Weiland; M M Salimans; W E Fibbe; P M Kluin; B J Cohen
Journal:  Br J Haematol       Date:  1989-02       Impact factor: 6.998

4.  Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein.

Authors:  H M Geysen; S J Barteling; R H Meloen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  Structure and mapping of the DNA of human parvovirus B19.

Authors:  J Mori; P Beattie; D W Melton; B J Cohen; J P Clewley
Journal:  J Gen Virol       Date:  1987-11       Impact factor: 3.891

6.  Immunological properties of hepatitis B core antigen fusion proteins.

Authors:  M J Francis; G Z Hastings; A L Brown; K G Grace; D J Rowlands; F Brown; B E Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

7.  Characterization of monoclonal antibodies against human parvovirus B19.

Authors:  N Yaegashi; K Tada; H Shiraishi; T Ishii; K Nagata; K Sugamura
Journal:  Microbiol Immunol       Date:  1989       Impact factor: 1.955

8.  A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus.

Authors:  S Kajigaya; T Shimada; S Fujita; N S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

9.  Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins.

Authors:  C S Brown; J W Van Lent; J M Vlak; W J Spaan
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

Review 10.  Human parvovirus B19 and pregnancy.

Authors:  L J Anderson; E S Hurwitz
Journal:  Clin Perinatol       Date:  1988-06       Impact factor: 3.430

View more
  11 in total

1.  Parvovirus diagnostics and vaccine production in insect cells.

Authors:  J I Casal
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

2.  Characterization of Parvovirus B19 genotype 2 in KU812Ep6 cells.

Authors:  Johannes Blümel; Anna Maria Eis-Hübinger; Albert Stühler; Claudia Bönsch; Matthias Gessner; Johannes Löwer
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  Acute-phase-specific heptapeptide epitope for diagnosis of parvovirus B19 infection.

Authors:  L Kaikkonen; H Lankinen; I Harjunpää; K Hokynar; M Söderlund-Venermo; C Oker-Blom; L Hedman; K Hedman
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

4.  Expression of Aleutian mink disease parvovirus capsid proteins in defined segments: localization of immunoreactive sites and neutralizing epitopes to specific regions.

Authors:  M E Bloom; D A Martin; K L Oie; M E Huhtanen; F Costello; J B Wolfinbarger; S F Hayes; M Agbandje-McKenna
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

Review 5.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 6.  Parvovirus B19 infection.

Authors:  J R Kerr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

7.  Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins.

Authors:  A Gigler; S Dorsch; A Hemauer; C Williams; S Kim; N S Young; S Zolla-Pazner; H Wolf; M K Gorny; S Modrow
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

Review 8.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

9.  The structure of human parvovirus B19.

Authors:  Bärbel Kaufmann; Alan A Simpson; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

10.  Minute virus of mice, a parvovirus, in complex with the Fab fragment of a neutralizing monoclonal antibody.

Authors:  Bärbel Kaufmann; Alberto López-Bueno; Mauricio G Mateu; Paul R Chipman; Christian D S Nelson; Colin R Parrish; José M Almendral; Michael G Rossmann
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.